NASDAQ:CNTX | Cash Flow Statement | Context Therapeutics Inc.

Complete source-backed cash-flow history.

Available history
2020-03-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$14.56M
2026-03-31-$8.68M$4,687.00-$11.43M$37,258.00-$37,258.00$0.00
2025-12-31-$13.03M$4,065.00-$8.94M$0.00-$2M$0.00
2025-09-30-$9.69M
2025-06-30-$8.83M
2025-03-31-$4.58M$4,055.00-$5.03M$33,948.00-$33,948.00-$15,268.00
2024-12-31-$3.34M$2,934.00-$4.91M$0.00$0.00$14.54M
2024-09-30-$17.46M
2024-06-30-$2.25M
2024-03-31-$3.67M$2,568.00-$4.36M$0.00$0.00$0.00
2023-12-31-$6.77M$2,568.00-$7.23M$0.00$0.00$0.00
2023-09-30-$5.87M
2023-06-30-$5.01M
2023-03-31-$6.31M$3,193.00-$5.73M$0.00$0.00$0.00
2022-12-31-$3.56M$3,194.00-$3.93M$0.00$0.00$0.00
2022-09-30-$3.85M
2022-06-30-$3.99M
2022-03-31-$3.44M$0.00-$3.82M$34,999.00-$34,999.00-$102,071.00
2021-12-31-$3.09M$0.00-$4.96M$0.00$0.00$54.23M
2021-09-30-$1.44M
2021-06-30-$5.03M
2021-03-31-$892,049.00-$1.72M$0.00$0.00$3.03M
2020-12-31-$784,749.00-$176,025.00$0.00$350,000.00
2020-09-30-$876,237.00
2020-06-30$7.48M
2020-03-31$826,480.00

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$36.12M$16,251.00-$26.39M$33,948.00-$2.03M-$15,268.00
2024-12-31-$26.73M$10,881.00-$14.56M$7,316.00-$14.76M$109.29M
2023-12-31-$23.96M$12,044.00-$21.05M$0.00$0.00$0.00
2022-12-31-$14.84M$9,268.00-$13.55M$36,836.00-$536,836.00-$102,071.00
2021-12-31-$10.46M$0.00-$8.8M$0.00-$250,000.00$58.39M
2020-12-31$6.64M-$1.03M$0.00$1.15M